134 related articles for article (PubMed ID: 1887425)
21. [Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations].
Alpa M; Ferrero B; Cavallo R; Naretto C; Gennaro M; Bellizia L; Sena LM; Roccatello D
G Ital Nefrol; 2002; 19(6):617-21. PubMed ID: 12508165
[TBL] [Abstract][Full Text] [Related]
22. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
Mak A; Cheung BM; Mok CC; Leung R; Lau CS
Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
[TBL] [Abstract][Full Text] [Related]
23. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
[TBL] [Abstract][Full Text] [Related]
24. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.
Siegert C; Daha M; Westedt ML; van der Voort E; Breedveld F
J Rheumatol; 1991 Feb; 18(2):230-4. PubMed ID: 2023216
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus infection in systemic lupus erythematosus: a case-control study.
Perlemuter G; Cacoub P; Sbaï A; Hausfater P; Thibault V; Le TH; Wechsler B; Buffet C; Piette JC
J Rheumatol; 2003 Jul; 30(7):1473-8. PubMed ID: 12858443
[TBL] [Abstract][Full Text] [Related]
26. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
Serikova SIu; Kozlovskaia NL; Shilov EM
Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
[TBL] [Abstract][Full Text] [Related]
27. Cryoglobulin studies in systemic lupus erythematosus.
Sikander F; Salgaonkar DS; Joshi VR
J Postgrad Med; 1989 Jul; 35(3):139-43. PubMed ID: 2634754
[TBL] [Abstract][Full Text] [Related]
28. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
29. Cryoimmunoglobulinaemia in patients with primary renal disease and systemic lupus erythematosus. I. IgG- and DNA-binding assessed by co-precipitation.
McPhaul JJ
Clin Exp Immunol; 1978 Jan; 31(1):131-40. PubMed ID: 639345
[TBL] [Abstract][Full Text] [Related]
30. Plasma fibronectin in systemic lupus erythematosus: relationship to clinical activity, DNA binding and acute phase proteins.
Carsons S; Parenti D; Lavietes BB; Diamond HS; Singer A; Boxer M
J Rheumatol; 1985 Dec; 12(6):1088-92. PubMed ID: 2419557
[TBL] [Abstract][Full Text] [Related]
31. [Importance of the determination of antibodies to n-DNA in systemic lupus erythematosus and other rheumatic diseases (comparative study of radioisotope and immunoenzyme technics)].
Riazantseva TA; Shakhanina KL; Aroian AA; Speranskiĭ AI
Ter Arkh; 1987; 59(8):86-91. PubMed ID: 3317973
[TBL] [Abstract][Full Text] [Related]
32. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
33. [Clinico-immunological characteristics of systemic lupus erythematosus with Raynaud and Sjögren's syndromes (report I)].
Nasonova VA; Poverennyĭ AM; Nasonov EL; Lekakh IV; Tachmuradova MD
Ter Arkh; 1985; 57(5):94-8. PubMed ID: 3161200
[TBL] [Abstract][Full Text] [Related]
34. Immune complexes in the pericardial fluid in systemic lupus erythematosus.
Quismorio FP
Arch Intern Med; 1980 Jan; 140(1):112-4. PubMed ID: 6965447
[TBL] [Abstract][Full Text] [Related]
35. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
37. Polymorphonuclear leucocyte fluorescence and cryoglobulin phagocytosis in systemic lupus erythematosus.
Losito A; Lorusso L
Clin Exp Immunol; 1979 Mar; 35(3):376-9. PubMed ID: 222518
[TBL] [Abstract][Full Text] [Related]
38. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus.
Suzuki N; Harada T; Mizushima Y; Sakane T
J Immunol; 1993 Jul; 151(2):1128-36. PubMed ID: 8335894
[TBL] [Abstract][Full Text] [Related]
39. [Various quantitative and qualitative characteristics of circulating immune complexes in rheumatic vasculitis].
Matulis AA; Venalis AI; Mishkinite GA; Tamuliavichene IV; Karlene VS
Ter Arkh; 1985; 57(8):72-5. PubMed ID: 2416074
[TBL] [Abstract][Full Text] [Related]
40. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia.
Kippner L; Klint C; Sturfelt G; Bengtsson AA; Eriksson H; Truedsson L
J Autoimmun; 2001 Jun; 16(4):471-8. PubMed ID: 11437496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
